Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Tinzaparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 8 Venous Thrombosis 5 Neoplasms 5 Thromboembolism 3 Pulmonary Embolism 3 Lung Neoplasms 3 Multiple Myeloma 2 Lymphoma 2 Colorectal Neoplasms 2 Vascular Diseases 1 Urogenital Neoplasms 1 Thrombosis 1 Thrombocytopenia 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Lymphoproliferative Disorders 1 Lymphatic Diseases 1 Leukemia 1 Kidney Neoplasms 1 Intestinal Neoplasms 1 Hemostatic Disorders 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Fluorouracil 189 Leucovorin 174 Oxaliplatin 169 Irinotecan 132 Bevacizumab 95 Capecitabine 77 Cetuximab 74 Folfox protocol 48 Chemotherapy, Adjuvant 31 Colonoscopy 26 Panitumumab 25 pembrolizumab 22 Drug Therapy 20 Floxuridine 18 Blood Specimen Collection 18 Radiotherapy 17 Nivolumab 17 IFL protocol 16 Gemcitabine 16 Surveys and Questionnaires 15 Exercise 15 Early Intervention, Educational 15 Laparoscopy 14 Immunohistochemistry 14 Celecoxib 14 Neoadjuvant Therapy 13 Magnetic Resonance Spectroscopy 13 Cyclophosphamide 13 Biopsy 13 trifluridine tipiracil drug combination 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01455831 2021-05-17

PERIOP-01

Ottawa Hospital Research Institute

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡